Business Context and Reporting Period
This Form 8-K was filed by FORM Holdings Corp. on October 25, 2016. The filing reports the entry into Amendment No. 2 to a previously announced Merger Agreement dated August 8, 2016, between FORM Holdings Corp., its subsidiary FHXMS, LLC, and XpresSpa Holdings, LLC. The transaction involves the merger of FHXMS, LLC with and into XpresSpa, with XpresSpa surviving as a wholly-owned subsidiary of FORM.
Key Financial Metrics and Transaction Terms
The filing details the consideration to be paid to XpresSpa unitholders upon completion of the Merger, rather than reporting standard operating financial metrics such as revenue or cash flow for a specific period.
- Common Stock Consideration: 2,500,000 shares of FORM Common Stock.
- Preferred Stock Consideration: 494,792 shares of Series D Convertible Preferred Stock with an aggregate initial liquidation preference of $23,750,000. These shares accrue dividends at 9% per annum and are initially convertible into 3,958,336 shares of FORM Common Stock.
- Warrant Consideration: Five-year warrants to purchase an aggregate of 2,500,000 shares of FORM Common Stock at an exercise price of $3.00 per share.
- Escrow Adjustment: The Amendment increases the amount to be held in escrow by $2 million to cover indemnification provisions.
The filing text does not provide clear values for FORM's or XpresSpa's current revenue, profit, cash flow, margins, or total debt levels.
Material Changes Versus Prior Period
The primary material change reported is the execution of Amendment No. 2 to the Merger Agreement. This amendment clarifies certain indemnification provisions and increases the escrow amount by $2 million compared to the original agreement terms. No comparative financial performance data is provided in this filing.
Guidance, Outlook, Risks, and Contingencies
Outlook and Status: The transaction is pending approval by stockholders. A Registration Statement on Form S-4 containing a proxy statement/prospectus was filed on September 9, 2016, and will be mailed to stockholders when effective.
Risks and Contingencies: The filing includes a cautionary note regarding forward-looking statements. Key risks identified include:
- The risk that FORM and XpresSpa may not be able to complete the proposed transaction.
- The inability to realize the potential value created by the Merger for equity holders.
- The inability to raise capital to fund operations and the business plan.
- FORM's inability to maintain the listing of its securities on the Nasdaq Capital Market after the Merger.
- Market acceptance of products and competition from other providers.
Management disclaims any obligation to update forward-looking statements.
Important Facts for Investor Verification
- Verify the terms of the proxy statement/prospectus filed on Form S-4 for complete details on the transaction and voting procedures.
- Confirm the final status of the $2 million escrow increase and the specific indemnification clauses clarified in Amendment No. 2 (Exhibit 2.1).
- Assess the risk of the transaction failing to close or the company failing to maintain its Nasdaq Capital Market listing.
- Review the conversion mechanics of the Series D Convertible Preferred Stock and the exercise terms of the warrants.